MetaADEDB 2.0 @ LMMD
ropinirole
(XDXHAEQXIBQUEZ-UHFFFAOYSA-N)
Structure
SMILES
CCCN(CCC)CCc1cccc2c1CC(=O)N2.Cl
Molecular Formula:
C16H25ClN2O
Molecular Weight:
296.836
Log P:
3.7857
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
32.34
CAS Number(s):
91374-20-8
Synonym(s)
1.
ropinirole
2.
4-(2-(di-n-propylamino)ethyl)-2(3H)-indolone
3.
Requip
4.
SK&F 101468
5.
SK&F-101,468
6.
SKF 101468
7.
ropinirol
8.
ropinirole hydrochloride
External Link(s)
MeSHC046649
PubChem Compound139059798
66766793
68727
ChEBI8889
CHEMBLCHEMBL1200411
KEGGdr:D00784
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
2NauseaFAERS: 30US FAERS
3MalaiseFAERS: 25US FAERS
4Drug administration errorFAERS: 13US FAERS
5SomnolenceFAERS: 13US FAERS
6TremorFAERS: 13US FAERS
7DizzinessFAERS: 12US FAERS
8FatigueFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Restless Legs SyndromeFAERS: 10US FAERS
10GamblingFAERS: 9US FAERS
11SyncopeFAERS: 9US FAERS
12HeadacheFAERS: 8US FAERS
13Product substitution issueFAERS: 8US FAERS
14Compulsive shoppingFAERS: 7US FAERS
15Medication residueFAERS: 7US FAERS
16Product quality issueFAERS: 7US FAERS
17Abdominal PainFAERS: 6US FAERS
18AnxietyFAERS: 6US FAERS
19DementiaFAERS: 6US FAERS
20Drug dispensing errorFAERS: 6US FAERS
21OverdoseFAERS: 6US FAERS
22Transaminases increasedFAERS: 6US FAERS
23PalpitationsFAERS: 5US FAERS
24Sudden onset of sleepFAERS: 5US FAERS
25VomitingFAERS: 5US FAERS
26ConstipationFAERS: 4US FAERS
27DiplopiaFAERS: 4US FAERS
28Drug dose omissionFAERS: 4US FAERS
29Gamma-Glutamyltransferase IncreasedFAERS: 4US FAERS
30Joint swellingFAERS: 4US FAERS
31Obsessive-Compulsive DisorderFAERS: 4US FAERS
32PainFAERS: 4US FAERS
33ParanoiaFAERS: 4US FAERS
34Abdominal discomfortFAERS: 3US FAERS
35Atrial FibrillationFAERS: 3US FAERS
36Back PainFAERS: 3US FAERS
37Chest PainFAERS: 3US FAERS
38Drug ineffective for unapproved indicationFAERS: 3US FAERS
39Hypoaesthesia facialFAERS: 3US FAERS
40LethargyFAERS: 3US FAERS
41NasopharyngitisFAERS: 3US FAERS
42TachycardiaFAERS: 3US FAERS
43Unevaluable eventFAERS: 3US FAERS
44Activities of daily living impairedFAERS: 2US FAERS
45Adverse eventFAERS: 2US FAERS
46AmnesiaFAERS: 2US FAERS
47AngerFAERS: 2US FAERS
48ArthralgiaFAERS: 2US FAERS
49AstheniaFAERS: 2US FAERS
50Blood glucose increasedFAERS: 2US FAERS
51BradycardiaFAERS: 2US FAERS
52CamptocormiaFAERS: 2US FAERS
53Cardiac ArrestFAERS: 2US FAERS
54Cerebrovascular accidentFAERS: 2US FAERS
55ChillsFAERS: 2US FAERS
56CholelithiasisFAERS: 2US FAERS
57DisorientationFAERS: 2US FAERS
58DissociationFAERS: 2US FAERS
59Drug abuseFAERS: 2US FAERS
60DyspepsiaFAERS: 2US FAERS
61Feeling abnormalFAERS: 2US FAERS
62General physical health deteriorationFAERS: 2US FAERS
63ImmobileFAERS: 2US FAERS
64Impaired work abilityFAERS: 2US FAERS
65Incorrect dose administeredFAERS: 2US FAERS
66InflammationFAERS: 2US FAERS
67Jealous delusionFAERS: 2US FAERS
68Maternal exposure during pregnancyFAERS: 2US FAERS
69Medication residue presentFAERS: 2US FAERS
70Muscle RigidityFAERS: 2US FAERS
71Neck PainFAERS: 2US FAERS
72NervousnessFAERS: 2US FAERS
73PresyncopeFAERS: 2US FAERS
74Product use in unapproved indicationFAERS: 2US FAERS
75PruritusFAERS: 2US FAERS
76Psychiatric symptomFAERS: 2US FAERS
77Pulmonary granulomaFAERS: 2US FAERS
78RestlessnessFAERS: 2US FAERS
79Retroperitoneal fibrosisFAERS: 2US FAERS
80Sexual abuseFAERS: 2US FAERS
81Sexual activity increasedFAERS: 2US FAERS
82SoporFAERS: 2US FAERS
83Suicide attemptFAERS: 2US FAERS
84SwellingFAERS: 2US FAERS
85Therapeutic response unexpectedFAERS: 2US FAERS
86UrticariaFAERS: 2US FAERS
87VertigoFAERS: 2US FAERS
88Wrong technique in drug usage processFAERS: 2US FAERS
89AbasiaFAERS: 1US FAERS
90Abnormal weight gainFAERS: 1US FAERS
91Accidental exposureFAERS: 1US FAERS
92Acute kidney injuryFAERS: 1US FAERS
93Acute myocardial infarctionFAERS: 1US FAERS
94Acute psychosisFAERS: 1US FAERS
95AgitationFAERS: 1US FAERS
96Allergic reaction to excipientFAERS: 1US FAERS
97AnuriaFAERS: 1US FAERS
98AphasiaFAERS: 1US FAERS
99AphoniaFAERS: 1US FAERS
100AppendicitisFAERS: 1US FAERS
101ArthropathyFAERS: 1US FAERS
102Back disorderFAERS: 1US FAERS
103BedriddenFAERS: 1US FAERS
104Blood alkaline phosphatase increasedFAERS: 1US FAERS
105Blood amylase increasedFAERS: 1US FAERS
106Blood cortisol increasedFAERS: 1US FAERS
107Blood creatinine increasedFAERS: 1US FAERS
108Blood glucose fluctuationFAERS: 1US FAERS
109Blood lactate dehydrogenase increasedFAERS: 1US FAERS
110Blood pressure orthostatic decreasedFAERS: 1US FAERS
111Blood prolactin decreasedFAERS: 1US FAERS
112Brain HypoxiaFAERS: 1US FAERS
113BronchitisFAERS: 1US FAERS
114BronchopneumoniaFAERS: 1US FAERS
115Cardiac ablationFAERS: 1US FAERS
116Cardiac ventricular disorderFAERS: 1US FAERS
117Carpal Tunnel SyndromeFAERS: 1US FAERS
118Cataract operationFAERS: 1US FAERS
119Central nervous system lesionFAERS: 1US FAERS
120Cerebral InfarctionFAERS: 1US FAERS
121Chest discomfortFAERS: 1US FAERS
122ChokingFAERS: 1US FAERS
123ClonusFAERS: 1US FAERS
124ColitisFAERS: 1US FAERS
125Completed SuicideFAERS: 1US FAERS
126Deja VuFAERS: 1US FAERS
127DependenceFAERS: 1US FAERS
128DisabilityFAERS: 1US FAERS
129Disease ProgressionFAERS: 1US FAERS
130DiverticulitisFAERS: 1US FAERS
131Drug DependenceFAERS: 1US FAERS
132Drug effect incompleteFAERS: 1US FAERS
133Drug prescribing errorFAERS: 1US FAERS
134Drug screen false positiveFAERS: 1US FAERS
135Drug withdrawal syndromeFAERS: 1US FAERS
136DysarthriaFAERS: 1US FAERS
137DysphoniaFAERS: 1US FAERS
138DystoniaFAERS: 1US FAERS
139Economic problemFAERS: 1US FAERS
140EnuresisFAERS: 1US FAERS
141EpistaxisFAERS: 1US FAERS
142ErythemaFAERS: 1US FAERS
143Euphoric moodFAERS: 1US FAERS
144Facial paralysisFAERS: 1US FAERS
145Feeling ColdFAERS: 1US FAERS
146Feelings of worthlessnessFAERS: 1US FAERS
147FormicationFAERS: 1US FAERS
148FrustrationFAERS: 1US FAERS
149GastrostomyFAERS: 1US FAERS
150HepatotoxicityFAERS: 1US FAERS
151HeterophoriaFAERS: 1US FAERS
152HyperacusisFAERS: 1US FAERS
153HypersensitivityFAERS: 1US FAERS
154HypotensionFAERS: 1US FAERS
155HypothyroidismFAERS: 1US FAERS
156IleusFAERS: 1US FAERS
157Implant site infectionFAERS: 1US FAERS
158Inappropriate schedule of drug administrationFAERS: 1US FAERS
159Infectious colitisFAERS: 1US FAERS
160InfluenzaFAERS: 1US FAERS
161Intentional drug misuseFAERS: 1US FAERS
162Intercepted drug prescribing errorFAERS: 1US FAERS
163Intervertebral Disc DegenerationFAERS: 1US FAERS
164Intestinal resectionFAERS: 1US FAERS
165LaryngitisFAERS: 1US FAERS
166Limb discomfortFAERS: 1US FAERS
167Limb injuryFAERS: 1US FAERS
168Lip swellingFAERS: 1US FAERS
169Live BirthFAERS: 1US FAERS
170Long QT SyndromeFAERS: 1US FAERS
171LymphomaFAERS: 1US FAERS
172Medication ErrorFAERS: 1US FAERS
173Memory impairmentFAERS: 1US FAERS
174Mental impairmentFAERS: 1US FAERS
175Metastatic NeoplasmFAERS: 1US FAERS
176Middle insomniaFAERS: 1US FAERS
177Mood swingsFAERS: 1US FAERS
178Muscle tightnessFAERS: 1US FAERS
179Musculoskeletal PainFAERS: 1US FAERS
180MyalgiaFAERS: 1US FAERS
181MydriasisFAERS: 1US FAERS
182NephrectomyFAERS: 1US FAERS
183Neutropenic sepsisFAERS: 1US FAERS
184Night sweatsFAERS: 1US FAERS
185No adverse eventFAERS: 1US FAERS
186Obsessive thoughtsFAERS: 1US FAERS
187Ocular HypertensionFAERS: 1US FAERS
188Oropharyngeal painFAERS: 1US FAERS
189Pancreatic carcinomaFAERS: 1US FAERS
190Panic DisorderFAERS: 1US FAERS
191Paranasal sinus discomfortFAERS: 1US FAERS
192Personality ChangeFAERS: 1US FAERS
193PneumoniaFAERS: 1US FAERS
194PneumonitisFAERS: 1US FAERS
195Post procedural infectionFAERS: 1US FAERS
196Product availability issueFAERS: 1US FAERS
197Product dose omissionFAERS: 1US FAERS
198Pulmonary arterial hypertensionFAERS: 1US FAERS
199Rehabilitation therapyFAERS: 1US FAERS
200Respiratory DepressionFAERS: 1US FAERS
201Respiratory FailureFAERS: 1US FAERS
202Respiratory arrestFAERS: 1US FAERS
203Respiratory distressFAERS: 1US FAERS
204Rotator cuff syndromeFAERS: 1US FAERS
205Schizoaffective DisorderFAERS: 1US FAERS
206Sexual DysfunctionFAERS: 1US FAERS
207ShopliftingFAERS: 1US FAERS
208Sinus ArrhythmiaFAERS: 1US FAERS
209Sinus bradycardiaFAERS: 1US FAERS
210Skin hypertrophyFAERS: 1US FAERS
211Sleep ParalysisFAERS: 1US FAERS
212SomnambulismFAERS: 1US FAERS
213Spinal column stenosisFAERS: 1US FAERS
214StaringFAERS: 1US FAERS
215StrabismusFAERS: 1US FAERS
216Suicide of relativeFAERS: 1US FAERS
217Suture ruptureFAERS: 1US FAERS
218Temperature regulation disorderFAERS: 1US FAERS
219Therapeutic response delayedFAERS: 1US FAERS
220Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
221Therapy cessationFAERS: 1US FAERS
222TorticollisFAERS: 1US FAERS
223Toxicity to various agentsFAERS: 1US FAERS
224TuberculosisFAERS: 1US FAERS
225Ventricular FibrillationFAERS: 1US FAERS
226Visual ImpairmentFAERS: 1US FAERS
227Weight decreasedFAERS: 1US FAERS
228Wrong technique in product usage processFAERS: 1US FAERS
229YawningFAERS: 1US FAERS
230jaundiceFAERS: 1US FAERS
231Inappropriate schedule of product administrationCanada Vigilance: 1Canada Vigilance
232Mental status changesCanada Vigilance: 1Canada Vigilance
233Product complaintCanada Vigilance: 1Canada Vigilance
234Urinary tract infectionCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.